Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Background Patients with atrial fibrillation (AF) and hypertension are at high risk for stroke. Previous studies have shown elevated risk of stroke in patients with AF who have a history of hypertension (regardless of blood pressure [BP] control) and in patients with elevated BP. We assessed the ass...
Main Authors: | Meena P. Rao, Sigrun Halvorsen, Daniel Wojdyla, Laine Thomas, John H. Alexander, Elaine M. Hylek, Michael Hanna, M. Cecilia Bahit, Renato D. Lopes, Raffaele De Caterina, Cetin Erol, Shinya Goto, Fernando Lanas, Basil S. Lewis, Steen Husted, Bernard J. Gersh, Lars Wallentin, Christopher B. Granger, the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://doi.org/10.1161/JAHA.115.002015 |
Similar Items
-
Cost-effectiveness of Apixaban for Stroke Prevention in Patients with Atrial Fibrillation in Algeria
by: Yazid Aoudia, et al. -
Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation.
by: Soyon Lee, et al.
Published: (2012-01-01) -
Secondary prevention of stroke in atrial fibrillation, use of apixaban: ARISTOTLE, AVERROES studies
by: V.A. Parfenov, et al.
Published: (2014-10-01) -
Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.
by: Jelena Stevanović, et al.
Published: (2014-01-01) -
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
by: Ahmad S. Hersi, et al.
Published: (2019-07-01)